Rimonabant pharmacokinetics in healthy and obese subjects.

被引：13
|
作者：
Turpault, S [1 ]
Kanamaluru, V [1 ]
Lockwood, GF [1 ]
Bonnet, D [1 ]
Newton, J [1 ]
机构：
[1] Sanofi Aventis, Malvern, PA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2006年 / 79卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2005.12.177
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P50 / P50
页数：1
相关论文
共 50 条
  • [1] Population pharmacokinetic analysis of rimonabant in healthy subjects.
    Ferron, GM
    Grandison, M
    Lockwood, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P43 - P43
  • [2] EFFECT OF RIFAMPIN ON THE PHARMACOKINETICS OF ERTUGLIFLOZIN IN HEALTHY SUBJECTS.
    Kumar, V.
    Sahasrabudhe, V.
    Liang, Y.
    Matschke, K.
    Shi, H.
    Fountaine, R. J.
    Hickman, A.
    Saur, D.
    Terra, S. G.
    Cutler, D. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S47 - S47
  • [3] The pharmacokinetics of tesaglitazar (GALIDA™) in healthy male subjects.
    Ericsson, H
    Samuelsson, S
    Bergstrand, S
    Fryklund, L
    Hamrén, B
    Heijer, M
    Öhman, P
    DIABETOLOGIA, 2003, 46 : A292 - A292
  • [4] Pharmacokinetics of Tapentadol in Healthy Elderly and Young Subjects.
    Smit, J. W.
    Haeufel, T.
    Ravenstijn, P.
    Brett, M.
    Kleideiter, E.
    Mangold, B.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1079 - 1079
  • [5] Pharmacoignetics of rimonabant in Japanese and caucasian subjects.
    Kanamaluru, Vanaja
    Cabanis, Marie-Jose
    Purkayastha, Jaideep
    Bonnet, Denis
    Lockwood, Graham
    Newton, John
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (09): : 1204 - 1204
  • [6] Pharmacokinetics (PK) and pharmacodynamics (PD) of lanoteplase in healthy subjects.
    Vachharajani, N
    Shyu, W
    Stouffer, B
    Raymond, R
    Liao, W
    Tay, L
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 180 - 180
  • [7] Population pharmacokinetics of cefixime in Chinese male healthy subjects.
    Cui, Y
    Zhou, Y
    Sun, P
    Zhao, X
    Liu, Y
    Sun, Z
    Lu, W
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P24 - P24
  • [8] Entecavir pharmacokinetics after multiple doses in healthy subjects.
    Yan, JH
    Bifano, M
    Nichola, P
    O'Mara, E
    Loizillon, E
    Zhang, DX
    Olsen, S
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1070 - 1070
  • [9] INDUCTIVE EFFECT OF RIFAMPIN ON THE PHARMACOKINETICS OF VORICONAZOLE IN HEALTHY SUBJECTS.
    Lee, S.
    Shin, D.
    Kim, S.
    Ji, S. C.
    Yoon, S. H.
    Cho, J. Y.
    Shin, S. G.
    Jang, I. J.
    Yu, K. S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S3 - S4
  • [10] Repaglinide pharmacokinetics in healthy & chronic liver disease subjects.
    Hatorp, V
    Haug-Pihale, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 187 - 187
12345